期刊
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
卷 41, 期 1, 页码 3-14出版社
SPRINGER
DOI: 10.1007/s11239-015-1311-6
关键词
Venous thromboembolism; Pulmonary embolism; Deep vein thrombosis; Thrombophlebitis; Epidemiology
资金
- Boehringer Ingelheim
- Daiichi Sankyo
- Janssen Pharmaceuticals
Venous thromboembolism (VTE) is categorized by the U.S. Surgeon General as a major public health problem. VTE is relatively common and associated with reduced survival and substantial health-care costs, and recurs frequently. VTE is a complex (multifactorial) disease, involving interactions between acquired or inherited predispositions to thrombosis and VTE risk factors, including increasing patient age and obesity, hospitalization for surgery or acute illness, nursing-home confinement, active cancer, trauma or fracture, immobility or leg paresis, superficial vein thrombosis, and, in women, pregnancy and puerperium, oral contraception, and hormone therapy. Although independent VTE risk factors and predictors of VTE recurrence have been identified, and effective primary and secondary prophylaxis is available, the occurrence of VTE seems to be relatively constant, or even increasing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据